XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Parent
Common Stock
Capital in Excess of Par Value
Cumulative Net Income
Cumulative Distributions
Non-controlling Interests
Total
Balance at beginning of period at Dec. 31, 2019 $ 776,943 $ 398 $ 867,346 $ 1,293,482 $ (1,384,283) $ 8,483 $ 785,426
Balance (in shares) at Dec. 31, 2019   39,752          
Equity activity              
Common stock cash distributions (22,581)       (22,581)   (22,581)
Vesting of performance-based stock units, including the payment of distributions (586)       (586)   (586)
Vesting of performance-based stock units, including the payment of distributions (in shares)   82          
Issuance of restricted stock   $ 1 (1)        
Issuance of restricted stock (in shares)   76          
Repurchase of common stock (18,012) $ (6) (18,006)       (18,012)
Repurchase of common stock (in shares)   (616)          
Stock-based compensation expense 1,777   1,777       1,777
Net income 63,633     63,633   89 63,722
Non-controlling interest distributions           (146) (146)
Other (3,545) $ (1) (3,544)       (3,545)
Other (in shares)   (76)          
Balance at end of period at Mar. 31, 2020 797,629 $ 392 847,572 1,357,115 (1,407,450) 8,426 806,055
Balance (in shares) at Mar. 31, 2020   39,218          
Balance at beginning of period at Dec. 31, 2019 776,943 $ 398 867,346 1,293,482 (1,384,283) 8,483 785,426
Balance (in shares) at Dec. 31, 2019   39,752          
Equity activity              
Net income             65,674
Balance at end of period at Jun. 30, 2020 778,894 $ 392 849,326 1,358,985 (1,429,809) 8,411 787,305
Balance (in shares) at Jun. 30, 2020   39,243          
Balance at beginning of period at Mar. 31, 2020 797,629 $ 392 847,572 1,357,115 (1,407,450) 8,426 806,055
Balance (in shares) at Mar. 31, 2020   39,218          
Equity activity              
Common stock cash distributions (22,359)       (22,359)   (22,359)
Issuance of restricted stock (7)   (7)       (7)
Issuance of restricted stock (in shares)   25          
Stock-based compensation expense 1,761   1,761       1,761
Net income 1,870     1,870   82 1,952
Non-controlling interest distributions           (97) (97)
Balance at end of period at Jun. 30, 2020 778,894 $ 392 849,326 1,358,985 (1,429,809) 8,411 787,305
Balance (in shares) at Jun. 30, 2020   39,243          
Equity activity              
Common stock cash distributions (22,368)       (22,368)   (22,368)
Stock-based compensation expense 1,693   1,693       1,693
Net income 12,217     12,217   121 12,338
Non-controlling interest distributions           (128) (128)
Other (19)   (19)       (19)
Other (in shares)   (1)          
Balance at end of period at Sep. 30, 2020 770,417 $ 392 851,000 1,371,202 (1,452,177) 8,404 778,821
Balance (in shares) at Sep. 30, 2020   39,242          
Equity activity              
Common stock cash distributions (22,368)       (22,368)   (22,368)
Issuance of restricted stock (1)   (1)       (1)
Stock-based compensation expense 1,781   1,781       1,781
Net income 17,573     17,573   92 17,665
Non-controlling interest distributions           (92) (92)
Balance at end of period at Dec. 31, 2020 767,402 $ 392 852,780 1,388,775 (1,474,545) 8,404 775,806
Balance (in shares) at Dec. 31, 2020   39,242          
Equity activity              
Common stock cash distributions (22,405)       (22,405)   (22,405)
Vesting of performance-based stock units, including the payment of distributions (764) $ 1 (1)   (764)   (764)
Vesting of performance-based stock units, including the payment of distributions (in shares)   109          
Stock-based compensation expense 1,852   1,852       1,852
Net income 13,762     13,762   88 13,850
Non-controlling interest distributions           (88) (88)
Cash paid for taxes in lieu of common shares (3,470)   (3,470)       (3,470)
Cash paid for taxes in lieu of common shares (in shares)   (84)          
Other (10) $ 1 (11)       (10)
Other (in shares)   95          
Balance at end of period at Mar. 31, 2021 756,367 $ 394 851,150 1,402,537 (1,497,714) 8,404 764,771
Balance (in shares) at Mar. 31, 2021   39,362          
Balance at beginning of period at Dec. 31, 2020 767,402 $ 392 852,780 1,388,775 (1,474,545) 8,404 775,806
Balance (in shares) at Dec. 31, 2020   39,242          
Equity activity              
Net income             32,180
Balance at end of period at Jun. 30, 2021 753,976 $ 394 852,959 1,420,776 (1,520,153) 8,404 762,380
Balance (in shares) at Jun. 30, 2021   39,374          
Balance at beginning of period at Mar. 31, 2021 756,367 $ 394 851,150 1,402,537 (1,497,714) 8,404 764,771
Balance (in shares) at Mar. 31, 2021   39,362          
Equity activity              
Common stock cash distributions (22,439)       (22,439)   (22,439)
Stock-based compensation expense 1,958   1,958       1,958
Net income 18,239     18,239   91 18,330
Non-controlling interest distributions           (91) (91)
Cash paid for taxes in lieu of common shares (103)   (103)       (103)
Cash paid for taxes in lieu of common shares (in shares)   (3)          
Other (46)   (46)       (46)
Other (in shares)   15          
Balance at end of period at Jun. 30, 2021 $ 753,976 $ 394 $ 852,959 $ 1,420,776 $ (1,520,153) $ 8,404 $ 762,380
Balance (in shares) at Jun. 30, 2021   39,374